Reaction #129

ord-80e16f813a4348d09194009ae04f2217

Reaction equation

CNC(=O)c1ccccc1Nc1cc(Cl)ncc1C#N
CNC(=O)c1ccccc1Nc1cc
Cc1nn(C)cc1N
Cc1nn(C)cc1N
CNC(=O)c1ccccc1Nc1cc(Nc2cn(C)nc2C)ncc1C#N
CNC(=O)c1ccccc1Nc1cc
Yield 50.0%

Solvents

Conditions

Temperature
90°CELSIUS

Procedure

2-(2-chloro-5-cyanopyridin-4-ylamino)-N-methylbenzamide (200 mg, 0.70 mmol), Palladium(II) acetate (12.53 mg, 0.06 mmol), 1,3-dimethyl-1H-pyrazol-4-amine (155 mg, 1.40 mmol), 9,9-Dimethyl-4,5-bis(diphenylphosphino)xanthene (48.4 mg, 0.08 mmol) and Cesium carbonate (273 mg, 0.84 mmol) were suspended in dioxane (5 mL) into a test tube. The reaction was purged for 5 mins with nitrogen and then heated to 90 °C for 24 hours with stirring. The reaction was cooled to cooled to RT. The crude product was purified by ion exchange chromatography, using an SCX column. The desired crude product was eluted from the column using 7M NH3/MeOH and fractions were evaporated to dryness to afford crude product .The crude product was purified by preparative HPLC (Waters XBridge Prep C18 OBD column, 5µ silica, 19 mm diameter, 100 mm length), using decreasingly polar mixtures of water (containing 1% NH3) and MeCN as eluents. Fractions containing the desired compound were evaporated to dryness to afford 2-(5-cyano-2-(1,3-dimethyl-1H-pyrazol-4-ylamino)pyridin-4-ylamino)-N-methylbenzamide (126 mg, 50.0 %) as a beige solid.

Source

750 AstraZeneca ELN dataset